{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:55:41Z","timestamp":1790434541669,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009809","name":"John T. Reid Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.joca.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:19:20Z","timestamp":1559733560000},"page":"1557-1563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Deleting Suppressor of Cytokine Signaling-3 in chondrocytes reduces bone growth by disrupting mitogen-activated protein kinase signaling"],"prefix":"10.1016","volume":"27","author":[{"given":"X.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Croker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.P.","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.joca.2019.05.018_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/JOE-11-0048","article-title":"The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification","volume":"211","author":"Mackie","year":"2011","journal-title":"J\u00a0Endocrinol"},{"issue":"14","key":"10.1016\/j.joca.2019.05.018_bib2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.joca.2019.05.018_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.gendis.2014.09.005","article-title":"Fibroblast growth factor (FGF) signaling in development and skeletal diseases","volume":"1","author":"Teven","year":"2014","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.joca.2019.05.018_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J\u00a0Clin Investig"},{"issue":"11","key":"10.1016\/j.joca.2019.05.018_bib5","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"De Benedetti","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.joca.2019.05.018_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jbmr.1485","article-title":"Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization","volume":"27","author":"Poulton","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.joca.2019.05.018_bib7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.38701","article-title":"Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis","volume":"66","author":"Liu","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.joca.2019.05.018_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ydbio.2008.05.555","article-title":"Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia","volume":"321","author":"Yang","year":"2008","journal-title":"Dev Biol"},{"issue":"3","key":"10.1016\/j.joca.2019.05.018_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"Pt 2","key":"10.1016\/j.joca.2019.05.018_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1242\/jcs.02740","article-title":"Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling","volume":"119","author":"Ben-Zvi","year":"2006","journal-title":"J\u00a0Cell Sci"},{"issue":"2","key":"10.1016\/j.joca.2019.05.018_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.joca.2019.05.018_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08977194.2012.687375","article-title":"The biology and mechanism of action of suppressor of cytokine signaling 3","volume":"30","author":"Babon","year":"2012","journal-title":"Growth Factors"},{"issue":"6","key":"10.1016\/j.joca.2019.05.018_bib13","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1210\/mend.16.6.0845","article-title":"Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b)","volume":"16","author":"Greenhalgh","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.joca.2019.05.018_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41467-017-00920-x","article-title":"Bone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6","volume":"8","author":"Cho","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.joca.2019.05.018_bib15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/ncb3067","article-title":"A\u00a0subset of chondrogenic cells provides early mesenchymal progenitors in growing bones","volume":"16","author":"Ono","year":"2014","journal-title":"Nat Cell Biol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458419310623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458419310623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:51:18Z","timestamp":1761018678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458419310623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1063458419310623"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2019.05.018","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deleting Suppressor of Cytokine Signaling-3 in chondrocytes reduces bone growth by disrupting mitogen-activated protein kinase signaling","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}